Skip to Content

← See all SENNA-S brands

SENNA-S by HealthLife of USA LLC

Medically reviewed on June 5, 2017

Dosage form: tablet, coated
Ingredients: SENNOSIDES 8.6mg, DOCUSATE SODIUM 50mg
Labeler: HealthLife of USA LLC
NDC Code: 69517-131

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Senna-S - Senna and Docusate Sodium Tablets, 8.6 mg & 50 mg

Drug Facts

Active ingredients Purpose (in each tablet)          Purpose

Docusate sodium 50 mg.......................................Stool softner

Sennosides 8.6 mg................................................Laxative

Uses
  • relieves occasional constipation (irregularity)
  • generally produces bowel movement in 6-12 hours

Warnings

Do not use
  • if you are now taking mineral oil, unless directed by a doctor
  • laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have
  • stomach pain
  • nausea
  • vomiting
  • noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

  • adults and children 12 years of age or older - starting dosage: 2 tablets once a day, maximum dosage: 4 tablets twice a day
  • children 6 to under 12 years - starting dosage: 1 tablet once a day, maximum dosage: 2 tablets twice a day
  • children 2 to under 6 years - starting dosage: 1/2 tablet once a day, maximum dosage: 1 tablet twice a day
  • children under 2 years - starting dosage: ask a doctor, maximum dosage: ask a doctor

Other information
  • each tablet contains: calcium 21 mg
  • each tablet contains: sodium 3 mg VERY LOW SODIUM
  • store at 25ºC (77ºF); excursions permitted between 15°-30°C (59°-86°F)
  • read all product information before using
  • TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING

Inactive ingredients

croscarmellose sodium, colloidal silicon dioxide, dicalcium phosphate, D&C Yellow # 10, FD&C Yellow # 6, hypromellose, microcrystalline cellulose, magnesium stearate, maltodextrin, polyethylene glycol, stearic acid, titanium dioxide

Questions or comments?

Call toll free 1-844-832-1138 Monday through Friday 9AM – 5PM EST or www.healthlifeofusa.com

PRINCIPAL DISPLAY PANEL

Compare to the Active Ingredients in Senokot-S®

*This product is not manufactured or distributed by Purdue Products L.P., owner of the registered trademark Senokot-S®.

Senna and Docusate Sodium Tablets, 8.6 mg and 50 mg

SENNA-S 
senna and docusate sodium tablets, 8.6 mg and 50 mg tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69517-131
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SENNOSIDES (SENNOSIDES) SENNOSIDES8.6 mg
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM 
SILICON DIOXIDE 
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE 
D&C YELLOW NO. 10 
FD&C YELLOW NO. 6 
HYPROMELLOSES 
CELLULOSE, MICROCRYSTALLINE 
MAGNESIUM STEARATE 
MALTODEXTRIN 
POLYETHYLENE GLYCOL 1000 
STEARIC ACID 
TITANIUM DIOXIDE 
Product Characteristics
ColororangeScoreno score
ShapeROUNDSize10mm
FlavorImprint CodeS35
Contains    
Packaging
#Item CodePackage Description
1NDC:69517-131-2525 POUCH in 1 BOX
12 TABLET, COATED in 1 POUCH
2NDC:69517-131-5050 POUCH in 1 BOX
22 TABLET, COATED in 1 POUCH
3NDC:69517-131-022 POUCH in 1 POUCH
32 TABLET, COATED in 1 POUCH
4NDC:69517-131-101000 BOTTLE in 1 BOTTLE
4NDC:69517-131-05500 BOTTLE in 1 BOTTLE
4NDC:69517-131-2424 CARTON in 1 BOTTLE
41 TABLET, COATED in 1 CARTON
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33403/07/2016
Labeler - HealthLife of USA LLC (079656178)
Establishment
NameAddressID/FEIOperations
Elysium Pharmaceutical Ltd.915664486manufacture(69517-131)

 
HealthLife of USA LLC

← See all SENNA-S brands

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide